KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response.

Ager, Casey R; Zhang, Mingxuan; Chaimowitz, Matthew; Bansal, Shruti; Obradovic, Aleksandar; Rogava, Meri; Melms, Johannes C; McCann, Patrick; Spina, Catherine; Drake, Charles G; Dallos, Matthew C; Izar, Benjamin

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response.

Ager, Casey R; Zhang, Mingxuan; Chaimowitz, Matthew; Bansal, Shruti; Obradovic, Aleksandar; Rogava, Meri; Melms, Johannes C; McCann, Patrick; Spina, Catherine; Drake, Charles G; Dallos, Matthew C; Izar, Benjamin.

bioRxiv ; 2023 Jan 02.

Article in En | MEDLINE | ID: mdl-36711647

Fulltext

Add to My VHL

Print

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: BioRxiv Year: 2023 Document type: Article Country of publication: Estados Unidos